8-KEarnings & ResultsExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (Aug 7, 2024)

Filed August 7, 2024For Securities:CVS

Summary

CVS Health Corporation (CVS) has filed an 8-K report on August 7, 2024, primarily to furnish a press release announcing its financial results for the three months ended June 30, 2024. While the 8-K itself does not contain detailed financial figures, it directs investors to the press release (Exhibit 99.1) for the specific operational and financial condition data. This filing is crucial for investors seeking the latest performance metrics and guidance from CVS Health. The key takeaway for investors is to review the furnished press release for comprehensive details on the second quarter 2024 performance. This includes revenue, profitability, segment-specific results, and any forward-looking statements or updates to guidance. The 8-K serves as the official notification of the release of this information, ensuring timely access for market participants.

Key Highlights

  • 1CVS Health furnished a press release on August 7, 2024, detailing its financial results for the second quarter ended June 30, 2024.
  • 2The 8-K filing incorporates the press release (Exhibit 99.1) by reference for detailed financial and operational information.
  • 3Investors should consult the press release for specific performance metrics, including revenue and earnings for Q2 2024.
  • 4The filing serves as an official notification of the release of Q2 2024 financial results.
  • 5Information furnished in this 8-K is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially report and furnish the press release announcing CVS Health's financial results for the second quarter ended June 30, 2024.

The detailed financial results for the second quarter ended June 30, 2024, are provided in the press release that is furnished as Exhibit 99.1 to this 8-K filing.

No, this specific 8-K filing does not contain the detailed Q2 financial numbers itself. It directs investors to the accompanying press release (Exhibit 99.1) for those figures.

This disclaimer means that while the information is being officially disclosed, it is not subject to the same legal liability under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed' with the SEC. It's a standard practice for earnings press releases furnished under Item 2.02.